Forum: Singapore should invest more in autism research

The number of children diagnosed with autism spectrum disorder (ASD) has been steadily increasing worldwide and Singapore is no exception. More families are navigating the complex challenges that come with supporting children on the spectrum. This reality calls for a deeper national commitment to research and innovation in autism therapies.

At present, much of the evidence that guides autism interventions in Singapore originates from studies conducted overseas.

While international data is widely available and valuable, relying too much on findings from other countries may not always account for differences in healthcare systems, education structures, cultural contexts and population characteristics.

Singapore has long positioned itself in biomedical science and healthcare innovation; it should also aspire to be at the forefront of autism research.

Investing more resources into local research and development (R&D) on therapies for ASD could potentially bring several benefits. First, it would allow Singapore to develop evidence-based approaches that are better tailored to our local population and support systems. Second, strong research capabilities could help identify interventions that improve developmental outcomes earlier and more effectively.

Better outcomes for individuals with ASD would not only improve the quality of life for families but may also reduce the long-term strain on social, educational and healthcare resources. When children with developmental challenges receive more effective early interventions, they often make greater gains and require fewer intensive supports later in life.

Singapore already has strong advantages for R&D in this area. Our healthcare system is highly regulated, our clinical standards are rigorous, and our institutions are internationally respected. These factors create a safe and credible setting for conducting meaningful clinical research.

At the same time, both government and private therapy institutions should be encouraged to explore innovative or experimental approaches within well-defined guidelines and supportive regulatory frameworks.

Responsible experimentation is key to discovering new methods that could meaningfully alleviate ASD symptoms. Breakthroughs in medical science often arise from the willingness to responsibly test new ideas.

Countries that invest in research and innovation will be better equipped to support their communities. Singapore should take a more proactive approach rather than relying largely on expanding facilities and services, which addresses only immediate needs.

We need to innovate, explore new approaches and trial therapies. With bold, well-guided research, Singapore has the opportunity to not just manage ASD but also to lead the world in solutions that can make a difference.

Caryn Lim